Two parallel and complementary studies conducted by the IDIBELL team led by Dr. Alessandra Giorgetti have succeeded in recreating models of GATA2 deficiency disease, a rare genetic disorder that affects fewer than 1 million people worldwide. Thanks to these new models developed by Dr. Giorgetti’s team, we now have a clearer understanding of the molecular process by which the hematopoietic stem cells of these patients become cancerous.
This article was originally published on MedicalXpress.com

